Link between potential hyper-activity of mTOR signalling pathway and cancer cells

NewsGuard 100/100 Score

The link between obesity and disease has been well documented. There's evidence now that obesity and cancer have a strong link, as they've shown in the United States at least 90,000 cancer deaths a year can be attributed to obesity. University of Alberta researcher Richard Lamb is on his way to understanding the correlation and it's a good example of how the scientific process works.

Lamb is studying a cell pathway in the human body that regulates cell growth. In their most recent work, Lamb and his research group have found that this pathway can be affected by sources not within the cell, specifically amino acid nutrients. Amino acids are the building blocks of tissues and muscle in the human body.

What makes this interesting is that these amino acids are found to be elevated in obese people. That means this signalling pathway, called mTOR, could be hyper-activated by these heightened amino acid nutrients and this could affect how human cells respond to stress and disease among a number of other things. Lamb and his team will now investigate if cancer cells are aided by this potential hyper-activity of the pathway.

Lamb's work is published in the prestigious journal Molecular Cell, and as is normal scientific process, this will elicit calls from researchers around the world who could have other ideas on why this pathway is relevant to disease.

Source: University of Alberta

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer